BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25411238)

  • 1. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
    Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.
    Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating vaspin levels and nutritional status and insulin resistance in polycystic ovary syndrome.
    Franik G; Plinta R; Madej P; Owczarek A; Bozentowicz-Wikarek M; Chudek J; Skrzypulec-Plinta V; Olszanecka-Glinianowicz M
    Ginekol Pol; 2020; 91(5):251-255. PubMed ID: 32495930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome.
    Wyskida K; Franik G; Owczarek AJ; Choręza P; Kocełak P; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Arch Gynecol Obstet; 2020 Oct; 302(4):1025-1031. PubMed ID: 32592042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
    Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
    Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.